{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:06:33Z","timestamp":1761541593427,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.brachy.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T09:11:36Z","timestamp":1615108296000},"page":"595-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ultra-long-term toxicity of prostate brachytherapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Elizabeth","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2021.01.001_bib1","first-page":"6","article-title":"Cancer statistics, 1998","volume":"48","author":"Landis","year":"1998","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2021.01.001_bib2","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/PAS.0000000000000749","article-title":"The surveillance, epidemiology, and end results (SEER) program and pathology: Toward strengthening the critical relationship","volume":"40","author":"Duggan","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.brachy.2021.01.001_bib3","first-page":"180","article-title":"Update of the NCCN guidelines for treatment of prostate cancer","volume":"11","author":"Millikan","year":"1997","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.brachy.2021.01.001_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","article-title":"American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer","volume":"44","author":"Nag","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.01.001_bib5","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/01.ju.0000154633.73092.8e","article-title":"12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"173","author":"Potters","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2021.01.001_bib6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.ijrobp.2009.03.049","article-title":"Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy","volume":"76","author":"Hinnen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.01.001_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2009.03.045","article-title":"Health-related quality of life up to six years after 125I brachytherapy for early-stage prostate cancer","volume":"76","author":"Roeloffzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.01.001_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1464-410X.2011.10460.x","article-title":"Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer","volume":"109","author":"Emara","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2021.01.001_bib9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-4295(99)00597-X","article-title":"Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer","volume":"55","author":"Krupski","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2021.01.001_bib10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(05)65970-8","article-title":"Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated","volume":"166","author":"Talcott","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2021.01.001_bib11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/cncr.10248","article-title":"The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients","volume":"94","author":"Bacon","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2021.01.001_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0360-3016(02)04600-X","article-title":"Long-term urinary quality of life after permanent prostate brachytherapy","volume":"56","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.01.001_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1464-410X.2004.05094.x","article-title":"Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer","volume":"94","author":"Bradley","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2021.01.001_bib14","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2005.07.116","article-title":"Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy","volume":"23","author":"Miller","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.01.001_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/bjc.2017.30","article-title":"Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: A nationwide survey","volume":"116","author":"Lehto","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2021.01.001_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(99)00355-7","article-title":"A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer","volume":"46","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.01.001_bib17","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.21865","article-title":"After prostate cancer: Predictors of well-being among long-term prostate cancer survivors","volume":"106","author":"Blank","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2021.01.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/COC.0b013e31819cd364","article-title":"Longitudinal analysis of genitourinary and bowel symptoms in prostate cancer patients following brachytherapy","volume":"33","author":"Eckman","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.01.001_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3816\/CGC.2007.n.023","article-title":"Incidence and clinical course of hemorrhagic radiation proctitis after iodine-125 prostate brachytherapy","volume":"5","author":"Mishra","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.brachy.2021.01.001_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-5347(05)68570-9","article-title":"Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer","volume":"162","author":"Lee","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2021.01.001_bib21","doi-asserted-by":"crossref","DOI":"10.3834\/uij.1944-5784.2010.04.16","article-title":"Undetectable prostate-specific antigen level following prostate brachytherapy: An apples-to-apples comparison with radical prostatectomy","volume":"03","author":"Barrett","year":"2010","journal-title":"Urotoday Int J"},{"key":"10.1016\/j.brachy.2021.01.001_bib22","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/annonc\/mdv392","article-title":"Statistical controversies in clinical research: Long-term follow-up of clinical trials in cancer","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2021.01.001_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2021.01.001_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijrobp.2008.11.043","article-title":"Urinary symptom flare in 712 125I prostate brachytherapy patients: Long-term follow-up","volume":"75","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.01.001_bib25","doi-asserted-by":"crossref","first-page":"853487","DOI":"10.1155\/2012\/853487","article-title":"Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer","volume":"2012","author":"Hunter","year":"2012","journal-title":"Prostate Cancer"},{"year":"2014","series-title":"US Department of Health and Human Services Vital and Health Statistics, Series 3, Number 36","key":"10.1016\/j.brachy.2021.01.001_bib26"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:15:37Z","timestamp":1761531337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472121000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1538472121000015"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2021.01.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-long-term toxicity of prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}